(Q74293705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Leuprolide acetate (30-mg depot every four months) in the treatment of advanced prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1 reference

R Sharifi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L D Knoll

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Smith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Kramolowsky

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

271-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

9 November 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900500-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900500-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900500-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0090-4295(97)00500-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9495710%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference